University of Texas at Austin Human Performance Laboratory
Austin, Texas, 78712, United States
NCT Number: NCT03352063
Prolonged sitting has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of prolonged sitting on response to a HFTT after a short term training period.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Austin, Texas, 78712, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will commit to sitting more than 11 hours per day and taking less than 5000 steps per day while participating in exercise training.
Subjects will commit to sitting less than 5 hours per day and taking more than 10000 steps per day while participating in exercise training.
Time frame: 6 hours
Areas under the curve for triglyceride concentration will be calculated for hourly samples from a 6-hour lipid tolerance test
Time frame: 6 hours
Areas under the curve for insulin concentration will be calculated for hourly samples from a 6-hour lipid tolerance test
Time frame: 6 hours
Areas under the curve for glucose concentration will be calculated for hourly samples from a 6-hour lipid tolerance test
University of Texas at Austin
Other
Effect of Prolonged Sitting on Metabolic and Cardiovascular Responses to Short-Term Exercise Training
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01447745
Arterial Occlusive Diseases, Arteriosclerosis
Québec, Canada
View Trial DetailsNCT03697382
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial DetailsNCT03098446
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial DetailsNCT03089437
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial Details